Cheers Joel, you summed it up nicely.
Agree @Antipater_100 - Nic can be as proactive as he wants in looking for more investment opportunities, but that should also include knowing when to exit or sell an asset (overall ALK have been good at his, but CAI leaves a stain).
Not sure if others have had a proper look at what Nic touched on in the interview in regards to the REX deal (RXM).
Basically, a copper/gold play in South Australia just got snapped up by MACH (Indo billionaire I believe) for just under $400m. The asset has been sitting there for a long time, but... times are changing. Large copper discoveries are a thing of the past. What I like is that this is proof that the investment thesis for large low grade deposits is changing, at least in regards to copper. I also like that, the RXM deposit is, much smaller than Boda/Kai (though the initial economics are better because the grades are better, though.... once you start comparing the actual production rates, it surprisingly similar.
I thought this was a particularly interesting slide, because... Hillside will soon be gone, though it will take ALK a while to tick off the permitting requirements etc, as pointed out by Anti, Boda/Kai is still a new discovery, with so much more drilling to come that will almost certainly expand the MRE, let alone drilling for other nearby deposits.
I note that the costings are from 2022... so... a tiny bit of inflation has likely crept into those figures.
Anyway, enough from me for now, ALK needs to bed down Roswell and build up some cash, whilst getting on with all the other parts of the business that need attention....
- Forums
- ASX - By Stock
- Ann: Boda-Kaiser Scoping Study
Cheers Joel, you summed it up nicely.Agree @Antipater_100 - Nic...
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
0.005(1.09%) |
Mkt cap ! $278.1M |
Open | High | Low | Value | Volume |
46.0¢ | 47.0¢ | 45.0¢ | $81.23K | 175.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3875 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 100508 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 41890 | 0.460 |
7 | 38596 | 0.455 |
9 | 81645 | 0.450 |
6 | 34535 | 0.445 |
11 | 27085 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 26151 | 10 |
0.470 | 99570 | 6 |
0.475 | 30480 | 7 |
0.480 | 59259 | 10 |
0.485 | 66919 | 4 |
Last trade - 10.41am 11/10/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online